MBIO (Mustang Bio) FCF Yield %: -97.29 (As of Jul. 14, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MBIO Mustang Bio Inc MBIO
30 GF Score
Price $0.68
! 2 Warning Signs
View Full Analysis

What is Mustang Bio FCF Yield %?

Mustang Bio MBIO -0.21% 30 FCF Yield % is -97.29 as of Jul. 14, 2026. GuruFocus rates MBIO with a GF Score™ of 30/100. The stock has 2 warning signs investors should review. Among 1,409 Biotechnology companies, Mustang Bio ranks worse than 90.49% on this metric.

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Mustang Bio's Trailing 12-Month Free Cash Flow is $-4.88 Mil, and Market Cap is $5.02 Mil. Therefore, Mustang Bio's FCF Yield % for today is -97.29%.

The historical rank and industry rank for Mustang Bio's FCF Yield % or its related term are showing as below:

MBIO' s FCF Yield % Range Over the Past 10 Years
Min: -103505.65   Med: -140.69   Max: -16.2
Current: -97.29


During the past 11 years, the highest FCF Yield % of Mustang Bio was -16.20%. The lowest was -103505.65%. And the median was -140.69%.

MBIO's FCF Yield % is ranked worse than
90.49% of 1409 companies
in the Biotechnology industry
Industry Median: -9.65 vs MBIO: -97.29

Mustang Bio's FCF Margin % for the quarter that ended in Mar. 2026 was 0.00%.


Mustang Bio FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Mustang Bio FCF Yield % Related Terms


Mustang Bio FCF Yield % Historical Data

* Premium members only.

The historical data trend for Mustang Bio's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Mustang Bio FCF Yield % Chart

Mustang Bio Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
FCF Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -26.20 -116.20 -72.53 -70.41 -73.52

Mustang Bio Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -131.78 -128.09 -29.49 -95.97 -73.08

MBIO vs ELAB, DRMA, PCSA: FCF Yield % Comparison

For the Biotechnology subindustry, Mustang Bio's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mustang Bio FCF Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Mustang Bio's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Mustang Bio's FCF Yield % falls into.


MBIO
30GF Score
Mustang Bio Inc MBIO
FCF Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Mustang Bio FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Mustang Bio's FCF Yield % for the fiscal year that ended in Dec. 2025 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-5.264 / 7.160319
=-73.52%

Mustang Bio's annualized FCF Yield % for the quarter that ended in Mar. 2026 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-1.008 * 4 / 5.5175714
=-73.08%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Yield % →
What does a FCF Yield % of -97.29 mean?
Mustang Bio (MBIO) has a FCF Yield % of -97.29 as of Jul. 14, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Mustang Bio and its competitors. According to the industry distribution chart, Mustang Bio ranks #1275 out of 1409 companies in the Biotechnology industry, placing it in the top 90.5%.
Is Mustang Bio's FCF Yield % too high?
Mustang Bio's current FCF Yield % is -97.29. Based on the distribution chart, Mustang Bio ranks #1275 out of 1409 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Mustang Bio has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does Mustang Bio's FCF Yield % compare to ELAB and DRMA?
According to the Biotechnology industry distribution chart, Mustang Bio ranks #1275 out of 1409 companies for FCF Yield %. This places Mustang Bio in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Biotechnology company?
A good FCF Yield % depends on the Biotechnology industry context. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Mustang Bio and its competitors. Mustang Bio's current FCF Yield % is -97.29. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mustang Bio stock overvalued right now?
Mustang Bio (MBIO) has a current FCF Yield % of -97.29. The current FCF Yield % is -97.29. Mustang Bio's overall GF Score™ is 30/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Mustang Bio (MBIO), the current FCF Yield % is -97.29 as of Jul. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Mustang Bio Business Description

Address 95 Sawyer Road, Suite 110, Waltham, MA, USA, 02453
Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs into potential cures for difficult-to-treat cancers. It acquires rights to these technologies by licensing or otherwise acquiring an ownership interest in the technologies, funding their research and development, and eventually either out-licensing or bringing the technologies to market. Its pipeline is currently focused on the core areas of gene therapies for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors.
30GF Score

Get the complete analysis for MBIO

FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.68
Price